Información de la revista
Vol. 20. Núm. 3.
Páginas 123-126 (marzo 2002)
Vol. 20. Núm. 3.
Páginas 123-126 (marzo 2002)
Acceso a texto completo
Neisseria gonorrhoeae resistente a quinolonas: un nuevo problema de salud pública en España
Visitas
12975
Luis Oteroa, Henar Villarb, Julio Alberto Vázquezc, Fernando Vázquezd,e,1
Autor para correspondencia
fvazquez@hmn.es
fvazquez@correo.uniovi.es
Correspondencia: Dr. F. Vázquez Valdés. Servicio de Microbiología. Hospital Monte Naranco. Avda. Dres. Fernández Vega, s/n. 33012 Oviedo.
fvazquez@correo.uniovi.es
Correspondencia: Dr. F. Vázquez Valdés. Servicio de Microbiología. Hospital Monte Naranco. Avda. Dres. Fernández Vega, s/n. 33012 Oviedo.
a Sección de Microbiología. Hospital de Cabueñes. Gijón
b Servicio de Microbiología. Hospital San Agustín. Avilés
c Laboratorio de Referencia de Neisserias. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Majadahonda. Madrid
d Servicio de Microbiología. Hospital Monte Naranco. Oviedo
e Departamento de Biología Funcional. Área de Microbiología. Facultad de Medicina. Universidad de Oviedo. España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
T. Baró, J. García Conesa, J.A. Vázquez, R. Miralles, C. Alia.
Estudio de la sensibilidad antimicrobiana, auxotipia, serotipia y análisis plasmídico de 75 cepas de Neisseria gonorrhoeae aisladas en Barcelona.
Med Clin (Barc), 92 (1989), pp. 765-768
[2.]
E.J. Perea, J.L. García-López, R. Martín, M. Calmet, R. Cisterna, V. Estébanez, et al.
Sensibilidad a antimicrobianos de 402 cepas de Neisseria gonorrhoeae aisladas en 7 ciudades de España.
Enferm Infec Microbiol Clin, 9 (1991), pp. 619-623
[3.]
T. Nebreda, F.J. Merino, A. Campos, M. Vázquez.
Variación de la incidencia y sensibilidad antibiótica de Neisseria gonorrhoeae en un período de 7 años.
Enferm Infecc Microbiol Clin, 14 (1996), pp. 441-443
[4.]
S. Berrón, J.A. Vázquez, M.J. Gimenez, L. de la Fuente, L. Aguilar.
In vitro susceptibilities of 400 spanish isolates of Neisseria gonorrhoeae to Gemifloxacin and 11 other antimicrobial agents.
Antimicrob Agents Chemother, 44 (2000), pp. 2543-2544
[5.]
A. Ibarra Corbillón, G. Saro Gutiérrez, M.J. Cabero Pérez, C. Carrera Villalante, J. García Rodríguez.
Actualización terapéutica de las enfermedades de transmisión sexual.
Enferm Infecc Microbiol Clin, 15 (1997), pp. 431-436
[6.]
Centers for Disease Control and Prevention. 1998 Sexually transmitted diseases treatment guidelines.
Morb Mortal Wkly Rep, 47 (1998), pp. 59-63
[7.]
J.S. Knapp JS.
Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.
Sex Transm Dis, 25 (1998), pp. 425-426
[8.]
R.J. Belland, S.G. Morrison, C. Ison, W.M. Huang.
Neisseria gonorrhoeae acquires mutations in analogous regions of gyr A and par C in fluoroquinolone-resistant isolates.
Mol Microbiol, 14 (1994), pp. 371-380
[9.]
D.C. Stein, R.J. Danaher, T.M. Cook.
Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.
Antimicrob Agents Chemother, 35 (1991), pp. 622-626
[10.]
T. Deguchi, M. Yasuda, M. Asano, K. Tada, H. Iwata, H. Komeda, et al.
DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae.
Antimicrob Agents Chemother, 39 (1995), pp. 561-563
[11.]
T. Deguchi, M. Yasuda, M. Nakano, S. Ozeki, Y. Ezaki, I. Saito, et al.
Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the parC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
Antimicrob Agents Chemother, 40 (1996), pp. 1020-1023
[12.]
National Neisseria Network of Australia. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999.
Pathol, 33 (2001), pp. 359-361
[13.]
J.A. Vázquez, S. Berrón, M.J. Giménez, L. de la Fuente, L. Aguilar.
In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents.
Eur J Clin Microbiol Infect Dis, 20 (2001), pp. 150-151
[14.]
T.R. Schultz, J.W. Tapsall, P.A. White, P.J. Newton.
An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones.
Antimicrob Agents Chemother, 44 (2000), pp. 1116
[15.]
J.E. Corkill, A. Percival, M. Lind.
Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.
J Antimicrob Chemother, 28 (1991), pp. 601-604
[16.]
M. Tanaka, H. Fukuda, K. Hirai, M. Hosaka, T. Matsumoto, J. Kumazawa.
Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.
Genitourin Med, 70 (1994), pp. 253-255
[17.]
H.H. Handsfield, W.L. Whittington.
Antibiotic-resistant Neisseria gonorrhoeae: the calm before another storm?.
Ann Intern Med, 125 (1996), pp. 507-509
[18.]
C.J. Carlyn, L.J. Doyle, C.C. Knapp, M.D. Lugwig, J.A. Washington.
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
Antimicrob Agents Chemother, 39 (1995), pp. 1606-1608
[19.]
J.W. Tapsall, E.A. Limnios, T.R. Shultz.
Continuing evolution of the pattern of quinolone resistance in Neisseria gonorrhoeae isolated in Sydney, Australia.
Sex Transm Dis, 25 (1998), pp. 415-417
[20.]
S.K. Schwarcz, J.M. Zenilman, D. Schnell, J.S. Knapp, E.W. Hook, S. Thompson, et al.
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The gonococcal Isolate Surveillance Project.
JAMA, 264 (1990), pp. 1413-1417
[21.]
K.M. Kam, K.K. Lo, C.F. Lai, Y.S. Lee, C.B. Chan.
Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong.
Antimicrob Agents Chemother, 37 (1993), pp. 2007-2008
[22.]
J.S. Knapp, J.A. Washington, L.J. Doyle, S.W. Neal, M.C. Parekh, R.J. Rice.
Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.
Antimicrob Agents Chemother, 38 (1994), pp. 2194-2196
[23.]
J.W. Tapsall, T.R. Shultz, A.E. Phillips.
Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to fluoroquinolone antibiotics.
Pathology, 24 (1994), pp. 27-31
[24.]
M. Tanaka, J. Kumazawa, T. Matsumoto, I. Kobayashi.
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Genotourin Med, 70 (1994), pp. 90-93
[25.]
Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to the fluoroquinolones – Ohio and Hawaii. 1992-1994.
Morb Mortal Wkly Rep, 43 (1994), pp. 325-327
[26.]
L. Ringuette, T. Trudeau, T. Turcotte, K. Yeung, R. Remes, L. Perron, et al.
Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin. Quebec, 1994-1995.
Can Commun Dis Rep, 22 (1996), pp. 121-125
[27.]
J.S. Knapp, C. Wongba, K. Limpakarnjanarat, N.L. Young, M.C. Parekh, et al.
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Sex Transm Dis, 24 (1997), pp. 142-148
[28.]
M.P. Joyce, Aying BB, Vaughan GH, Herip DS, Hayes CG, Espinosa G., et al.
In vitro sensitivity of Neisseria gonorrhoeae to fluoroquinolone antibiotics in the Republic of the Philippines.
6th International Pathogenic Neisseria Conference, (1988),
[29.]
A.E. Jephcott, A. Turner.
Ciprofloxacin resistance in gonococci [letter].
Lancet, 335 (1990), pp. 165
[30.]
K.M. Kam, K.K. Lo, K.Y.H. Ng, M.M. Cheung.
Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.
Genitourin Med, 71 (1995), pp. 141-144
[31.]
M. Tanaka, T. Matsumoto, T. Kobayashi, U. Uchino, J. Kumazawa.
Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.
Antimicrob Agents Chemother, 39 (1995), pp. 2367-2370
[32.]
K.M. Kam, P.W. Wong, M.M. Cheung, N.K.Y. Ho.
Detection of fluoroquinolone-resistant Neisseria gonorrhoeae.
J Clin Microbiol, 34 (1996), pp. 1462-1464
[33.]
J.W. Tapsall, E.A. Phillips, T.R. Shultz, C. Thacker.
Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995.
Sex Transm Dis, 23 (1996), pp. 425-428
[34.]
J.W. Tapsall, R. Lovett, R. Munro.
Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhea.
Med J Aust, 156 (1992), pp. 143
[35.]
H. Birley, P. McDonald, P. Carey, J. Fletcher.
High level ciprofloxacin resistance in Neisseria gonorrhoeae.
Genitourin Med, 70 (1994), pp. 292-293
[36.]
A.J. Neeling, M. van Santen-Verheuvel, J. Spaargaren, R.J.L. Willems.
Antimicrobial resistance of Neisseria gonorrhoeae and emeging ciprofloxacin resistance in The Netherlands, 1991 to 1998.
Antimicrob Agents Chemother, 44 (2000), pp. 3184-3185
[37.]
L. Otero, B. Alcala, J.A. Varela, M.D. Miguel, J.A. Vázquez, F. Vázquez.
First isolate of a Neisseria gonorrhoeae strain associated with an ofloxacin treatment failure in Spain.
Sex Transm Dis, 28 (2001), pp. 576-578
[38.]
X. Su, I. Lind.
Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Antimicrob Agents Chemother, 45 (2001), pp. 117-123
[39.]
A. Mavroidi, L.S. Tzouvelekis, P.T. Tassios, A. Flemetakis, M. Danilidou, E. Tzelepi.
Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.
J Clin Microbiol, 38 (2000), pp. 3489-3491
[40.]
M. Dan, F. Poch, D. Shpitz, B. Sheinberg.
High-level ciprofloxacin resistance in Neisseria gonorrhoeae: first report from Israel.
Emerg Infect Dis, 7 (2001), pp. 158-159
[41.]
R. Llanes, J. Sosa, D. Guzmán, Y. Gutiérrez, A. Llop, O. Ricardo.
Neisseria gonorrhoeae resistant to ciprofloxacin. First report in Cuba.
Sex Transm Dis, 28 (2001), pp. 82-83
[42.]
J.S. Knapp, K.K. Fox, D.L. Trees, W.L. Whittington.
Fluoroquinolone resistance in Neisseria gonorrhoeae.
Emerg Infect Dis, 3 (1997), pp. 33-39
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados